Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
A focused look at volatility by index, comparing metrics like daily ranges and swing intensity to help you benchmark market behavior.
19,819 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Young men are flocking to prediction markets for quick payouts and heightened excitement, but analysts warn the bets ...
A surge in AI investment nears $800 billion in 2026, and analysts warn the Fed’s inflation battle could turn the AI s...
As the US Treasury aims to rebuild its cash balance toward 900B by June, Bitcoin traders face a potential liquidity s...
Emerging frontier AI models are changing how we spot flaws in crypto systems. This in-depth look explains what fronti...
Bitcoin climbs after Trump suggests an Iran deal is near, sparking a risk-on move in crypto markets. Prices hit aroun...
Micron shares plunged after a broad AI memory demand pullback raised questions about the chip maker's cycle. Analysts...
As the Fed signals potential slower rate moves, tech stocks gyrate. The standout is a cash-generating giant deliverin...
A Tony moment becomes a teachable moment for money and planning. This feature breaks down how Broadway earnings work,...
Oracle enters a critical earnings season with eyes on its AI pivot and data-center expansion. The market has piled on...
A 65-year-old widow faces a pivotal decision: switch to her own Social Security benefit now or wait, risking a smalle...
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...